Sarissa Capital Domestic Fund Lp - Net Worth and Insider Trading

Sarissa Capital Domestic Fund Lp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sarissa Capital Domestic Fund Lp owns 2 companies in total, including Seelos Therapeutics Inc (SEEL) , and VIVUS Inc (VVUSQ) .

Click here to see the complete history of Sarissa Capital Domestic Fund Lp’s form 4 insider trades.

Insider Ownership Summary of Sarissa Capital Domestic Fund Lp

Ticker	Comapny	Transaction Date	Type of Owner
SEEL	Seelos Therapeutics Inc	2016-01-12	10 percent owner
VVUSQ	VIVUS Inc	2013-07-19	other: See Footnotes Below

Sarissa Capital Domestic Fund Lp Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Sarissa Capital Domestic Fund Lp Ownership Network

Ownership Network List of Sarissa Capital Domestic Fund Lp

No Data

Ownership Network Relation of Sarissa Capital Domestic Fund Lp

Sarissa Capital Domestic Fund Lp Owned Company Details

What does Seelos Therapeutics Inc do?

Who are the key executives at Seelos Therapeutics Inc?

Sarissa Capital Domestic Fund Lp is the 10 percent owner of Seelos Therapeutics Inc. Other key executives at Seelos Therapeutics Inc include director & See Remarks Raj Mehra , Chief Financial Officer Michael Joseph Golembiewski , and SVP & Chief Business Officer Neil Morton .

Seelos Therapeutics Inc (SEEL) Insider Trades Summary

Over the past 18 months, Sarissa Capital Domestic Fund Lp made no insider transaction in Seelos Therapeutics Inc (SEEL). Other recent insider transactions involving Seelos Therapeutics Inc (SEEL) include a net purchase of 83,000 shares made by Michael Joseph Golembiewski , and a net purchase of 75,757 shares made by Raj Mehra .

In summary, during the past 3 months, insiders sold 0 shares of Seelos Therapeutics Inc (SEEL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Seelos Therapeutics Inc (SEEL) were sold and 19,845 shares were bought by its insiders, resulting in a net purchase of 19,845 shares.

Seelos Therapeutics Inc (SEEL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Seelos Therapeutics Inc Insider Transactions

No Available Data

Sarissa Capital Domestic Fund Lp Mailing Address

Above is the net worth, insider trading, and ownership report for Sarissa Capital Domestic Fund Lp. You might contact Sarissa Capital Domestic Fund Lp via mailing address: 660 Steamboat Road, 3rd Floor, Greenwich Ct 06830.

Discussions on Sarissa Capital Domestic Fund Lp

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.